NXTS (Nexentis Technologies) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NXTS Nexentis Technologies Inc NXTS
44 GF Score
Price $1.88
GF Value $3.38
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Nexentis Technologies Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NXTS
44GF Score
Nexentis Technologies Inc NXTS
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nexentis Technologies (NXTS) Overvalued in 2026?

Based on GuruFocus' analysis, Nexentis Technologies stock appears to be undervalued. The current stock price of $1.88 is trading 44.4% below its estimated GF Value™ of $3.38. GuruFocus considers Nexentis Technologies to be Possible Value Trap.

Key valuation signals for NXTS:

  • Short Ratio:
  • GF Value™: $3.38 vs. price of $1.88 (44.4% below fair value)
  • GF Score™: 44/100 with 2 warning signs

No single metric tells the full story. See the NXTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nexentis Technologies Business Description

Address Pinhas Sapir Street 3, Kiryat HaMada, Ness Ziona, ISR, 7403626
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
44GF Score

Get the complete analysis for NXTS

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.88
Price
$3.38
GF Value